What is Arcutis Biotherapeutics, Inc.'s net income?

Arcutis Biotherapeutics, Inc. (ARQT) reported net income of -$11.3M in Q1 2026.

How has Arcutis Biotherapeutics, Inc.'s net income changed year-over-year?

Arcutis Biotherapeutics, Inc.'s net income increased by 54.9% year-over-year, from -$25.06M to -$11.3M.

What is the long-term trend for Arcutis Biotherapeutics, Inc.'s net income?

Over 3 years (2021 to 2024), Arcutis Biotherapeutics, Inc.'s net income has grown at a -12.1% compound annual growth rate (CAGR), from -$206.36M to -$140.04M.

What does net income mean?

Net income as the starting point for the indirect method operating cash flow reconciliation.

Arcutis Biotherapeutics, Inc. ARQT Net Income

Net Income at other companies

PfizerPFE

$2.7B-9.3%

AmgenAMGN

$1.82B+5.1%

IncyteINCY

$303.33M+91.7%

OrganonOGN

$146M+67.8%

Kymera TherapeuticsKYMR

-$69.23M-5.6%

Kiniksa Pharmaceuticals International, plcKNSA

$22.59M+165%

Segments

By segment

See full

Reportable Segment-$11.3M+54.9%

Other financials

Income statement

See full

Revenue$105.4M+60.1%

Gross profit$95.6M+67.7%

Operating income-$9.1M+62.9%

Net income-$11.3M+54.9%

EPS (diluted)-$0.09+55.0%

Balance sheet

See full

Cash & equivalents$35.1M-34.7%

Total debt$114.7M+3.5%

Total equity$189.6M+32.9%

Total assets$460.0M+33.7%

Cash flow

See full

Operating cash flow$2.2M+107%

CapEx--100%

Free cash flow$2.2M+107%

Valuation

See full

Market cap$3.28B+57.5%

Enterprise value$3.36B+57.0%

P/S7.9×-1.9×

Profitability

See full

Gross margin90.9%+2.5pp

Operating margin-12%-5.7pp

Net margin-13.9%-6.6pp

FCF margin-52.5%-21.9pp

Returns & leverage

See full

Return on equity-28.2%-13.0pp

Debt / equity0.6×-0.2×

Current ratio2.7×-0.9×

Where this comes from

Reported directly by Arcutis Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arcutis Biotherapeutics, Inc.'s net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Arcutis Biotherapeutics, Inc.'s net income?: Arcutis Biotherapeutics, Inc. (ARQT) reported net income of -$11.3M in Q1 2026.
How has Arcutis Biotherapeutics, Inc.'s net income changed year-over-year?: Arcutis Biotherapeutics, Inc.'s net income increased by 54.9% year-over-year, from -$25.06M to -$11.3M.
What is the long-term trend for Arcutis Biotherapeutics, Inc.'s net income?: Over 3 years (2021 to 2024), Arcutis Biotherapeutics, Inc.'s net income has grown at a -12.1% compound annual growth rate (CAGR), from -$206.36M to -$140.04M.
What does net income mean?: Net income as the starting point for the indirect method operating cash flow reconciliation.